Evaluation of the persistent activity of moxidectin (10%) long-acting (LA) injectable formulation against Dictyocaulus viviparus, Haemonchus placei, Trichostrongylus axei and Oesophagostomum radiatum infections in cattle

2010 ◽  
Vol 167 (1) ◽  
pp. 50-54 ◽  
Author(s):  
S. Ranjan ◽  
R. Search ◽  
E. Szewczyk ◽  
D. Amodie ◽  
R. Pollet ◽  
...  
Keyword(s):  
Persistent Activity ◽  
Dictyocaulus Viviparus ◽  
Injectable Formulation ◽  
Long Acting ◽  
Haemonchus Placei

Persistent efficacy of a long acting injectable formulation of moxidectin against natural infestations of the sheep nasal bot (Oestrus ovis) in Spain

2012 ◽  
Vol 188 (3-4) ◽  
pp. 330-336 ◽  
Author(s):  
Douglas Rugg ◽  
Luis Miguel Ferrer ◽  
Patxi Sarasola ◽  
Luis Figueras ◽  
Delia Lacasta ◽  
...  
Keyword(s):  
Oestrus Ovis ◽  
Injectable Formulation ◽  
Long Acting

Intraindividual and Interindividual Variability of Olanzapine Trough Concentrations in Patients Treated With the Long-Acting Injectable Formulation

2018 ◽  
Vol 38 (4) ◽  
pp. 365-369 ◽  
Author(s):  
Sara Baldelli ◽  
Massimo C. Mauri ◽  
Chiara Di Pace ◽  
Silvia Paletta ◽  
Alessandra Reggiori ◽  
...  
Keyword(s):  
Interindividual Variability ◽  
Injectable Formulation ◽  
Trough Concentrations ◽  
Long Acting

Development of a long-acting intramuscularly injectable formulation with nanosuspension of andrographolide

2016 ◽  
Vol 35 ◽  
pp. 327-332 ◽  
Author(s):  
Liandong Hu ◽  
Chenchen Yang ◽  
Dongqian Kong ◽  
Qiaofeng Hu ◽  
Na Gao ◽  
...  
Keyword(s):  
Injectable Formulation ◽  
Long Acting

scholarly journals Efficacy of moxidectin long-acting injectable formulation (1mg/kg bodyweight) against first instar larvae of Oestrus ovis in naturally infected sheep

2013 ◽  
Vol 193 (1-3) ◽  
pp. 320-324 ◽  
Author(s):  
M. Martínez-Valladares ◽  
F. Valcárcel ◽  
M.A. Álvarez-Sánchez ◽  
C. Cordero-Pérez ◽  
N. Fernández-Pato ◽  
...  
Keyword(s):  
Infected Sheep ◽  
Oestrus Ovis ◽  
Injectable Formulation ◽  
First Instar ◽  
Long Acting

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment

2009 ◽  
Vol 72 (3) ◽  
pp. 502-508 ◽  
Author(s):  
Lieven Baert ◽  
Gerben van ‘t Klooster ◽  
Willy Dries ◽  
Marc François ◽  
Alfons Wouters ◽  
...  
Keyword(s):  
Hiv Treatment ◽  
Injectable Formulation ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document